Prevalence of Vision Loss in North Africa and Middle East in 2020: Magnitude and Temporal Trends by Vision Loss Expert Group of the Global Burden of Disease Study (20987841)

“…Between 2000 and 2020, age-standardised prevalence of blindness and other categories of visual impairment decreased in all ages and among adults over than 50 years.…”

Data Sheet 1_Enhanced computerized cognitive remediation therapy improved cognitive function, negative symptoms, and GDNF in male long-term inpatients with schizophrenia.zip by Peiyun Zhang (4484194)

Data Sheet 1_Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greate... by Ayman Alhejazi (21092054)

“…Furthermore, CR and very good partial remission rates decreased across all treatment lines. Renal impairment decreased across different treatment lines, from 23.6% in the first line to 6.3% in the fourth line. …”

Early and progressive microstructural damage is present in Fabry disease. by Jacob W. Johnson (20172850)

Presentation 1_Telehealth coaching in older adults, behavior change, and impacts of the COVID-19 pandemic: analyses from The Brain Health Champion Study.pdf by Brittany McFeeley (21104825)

“…</p>Discussion<p>Our findings suggest that pandemic restrictions significantly impacted activities typically done outside the home (social and physical activity), while those feasibly achieved at home were less affected (Mediterranean diet adherence and cognitive activity). …”

Data Sheet 1_Crosstalk between MSC-extracellular vesicles and Olea europaea leaf extract in encapsulated liposomal hydrogel: attenuation of neuroinflammation and brain neurotransmi... by Doaa Ibrahim (12910718)

“…Impairments in behavioral tasks and memory were significantly improved in the group treated with the combined MSC-Exo and Lipo-OLE-Hydrogel therapy, with the MSC-Exo-alone group showing moderate improvement. …”

dsAg<i>TL2</i> embryos have altered lipid profiles. by Maurice A. Itoe (9930475)

Multiple comparisons after ANOVA(CR10). by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Homogeneity test of CR10. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Illustration of the fNIRS device worn. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Analysis of variance of HbO₂ in bilateral PFC. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

fNIRS equipment coordinates. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Changes of muscle oxygen saturation. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Analysis of variance of CR10. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Placement on the forehead. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

IMW intervention plan design. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

AgTL2 embryos have altered lipids, metabolites, and transcriptional profiles during development. by Maurice A. Itoe (9930475)

EPB-113 binds to hexameric nsp15 protein. by Benjamin Van Loy (9496075)

Data_Sheet_1_Subthreshold amyloid deposition, cerebral small vessel disease, and functional brain network disruption in delayed cognitive decline after stroke.docx by Jae-Sung Lim (532986)

“…Background<p>Although its incidence is relatively low, delayed-onset post-stroke cognitive decline (PSCD) may offer valuable insights into the “vascular contributions to cognitive impairment and dementia,” particularly concerning the roles of vascular and neurodegenerative mechanisms. …”

<b>Triptolide alleviates </b><b>cognitive</b><b> impairment via </b><b>autophagy</b><b> and Akt/mTOR/p70S6K pathway in an APP/PS1 Alzheimer’s disease mouse model</b> by xinyao Qi (21686459)

“…</p><p dir="ltr">The Morris Water Maze (MWM) test assessed cognitive function, where TP treatment significantly decreased escape latencies in AD mice without affecting swimming speeds, suggesting improved spatial learning and memory independent of motor function. …”